The sodium chloride 0.9 percent injection shortage is resolved, and it will be removed from the FDA Drug Shortage Database; facilities are advised to use FDA-approved products when available. The FDA ...

The nationwide shortage of sodium chloride 0.9% intravenous saline has officially ended, according to the FDA.

The agency is recommending that hospitals, health systems and clinics use the FDA-approved drug when available.

Around 86% of US healthcare providers reported IV fluid shortages following damage to Baxter’s North Carolina facility by ...

The FDA has declared the nationwide shortage of sodium chloride 0.9% IV saline over, crediting joint efforts with federal and industry partners. Supply is restored, but the agency will continue ...

For other IV fluids still in short supply, the FDA is working with manufacturers to monitor the supply, FDA Commissioner ...